COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
申请人:Plexxikon Inc.
公开号:US20130303534A1
公开(公告)日:2013-11-14
Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.